Results 181 to 190 of about 165,861 (406)

Degradation pathway of cephalosporin antibiotics by in vitro cultures of Lentinula edodes and Imleria badia

open access: green, 2017
Monika Dąbrowska   +4 more
openalex   +2 more sources

European Network for Optimization of Veterinary Antimicrobial Therapy (ENOVAT) 2025 guidelines for surgical antimicrobial prophylaxis in dogs and cats

open access: yesJournal of Small Animal Practice, EarlyView.
Surgical antimicrobial prophylaxis involves the administration of antimicrobials to reduce the risk of a surgical site infection and represents a significant proportion of all antimicrobial use in cats and dogs. This evidence‐based, European Network for Optimization of Veterinary Antimicrobial Therapy guideline provides recommendations for both peri ...
F. Allerton   +21 more
wiley   +1 more source

Canine chronic idiopathic rhinitis: management and outcome – a single‐centre retrospective observational study

open access: yesJournal of Small Animal Practice, EarlyView.
Objectives Canine chronic idiopathic rhinitis is a common cause of nasal disease in dogs but data reporting outcomes following treatment is lacking. The aim was to describe pre‐ and post‐referral management and outcomes of dogs diagnosed with canine chronic idiopathic rhinitis at a single referral centre.
P. M. N. Henry   +5 more
wiley   +1 more source

Multidrug resistance of bacterial pathogens in canine pyometra

open access: yesJournal of Small Animal Practice, EarlyView.
Objectives To characterise multidrug antimicrobial resistance and pathogenicity profiles of bacteria isolated from different anatomical sites in bitches with pyometra, emphasising their clinical relevance for diagnosis and therapeutic decision‐making in small animal practice.
M. G. M. Camozzi   +7 more
wiley   +1 more source

Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins

open access: yesAntimicrobial Agents and Chemotherapy, 2015
M. Berrazeg   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy